Published 8 months ago

Top US Court to Hear Challenge to Purdue Pharma's $6 Billion Opioid Settlement

The Supreme Court is hearing oral arguments regarding the approval of a controversial agreement by OxyContin-maker Purdue Pharma, which would provide billions of dollars to victims of the opioid epidemic while protecting the Sackler family from lawsuits.
The deal involves the Sackler family paying between $5.5 billion to $6 billion to help fight the opioid crisis, with the majority going to states, local governments, and Native American tribes.
If approved, the settlement would shield the Sackler family from future lawsuits and create a new company, Knoa Pharma, to distribute opioid addiction treatments and overdose reversal medicines.

Insights by Ground AI

Does this summary seem wrong?

0 Articles

All

Left

Center

Right

Times of India

Supreme Court weighs landmark Purdue Pharma settlement impacting opioid crisis

The Supreme Court weighs a pivotal Purdue Pharma settlement shielding the Sackler family from opioid crisis lawsuits. The $6 billion agreement, aimed at combatting the epidemic, faces scrutiny over extending bankruptcy protection to non-bankrupt individuals. Supporters view it as crucial, while critics decry special treatment for the Sacklers. The verdict, expected by summer, could reshape opioid litigation, offering direct payouts to victims an…

8 months ago·India

Read Full Article

News18 India

Top US Court to Hear Challenge to Purdue Pharma's $6 Billion Opioid Settlement

US Supreme Court to hear challenge on Purdue Pharma's $6 billion opioids settlement, questioning immunity for Sackler family amid opioid epidemic fallout

8 months ago·India

Read Full Article

CTV News

The U.S. Supreme Court wrestles with OxyContin maker's bankruptcy deal, with billions of dollars at stake

The U.S. Supreme Court on Monday wrestled with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.

8 months ago·Canada

Read Full Article

The Independent

Will the Supreme Court protect Purdue Pharma’s Sackler family from opioid lawsuits?

A bankruptcy case before the Supreme Court could grant the Sackler family immunity from opioid-related civil cases Ariana Baio reports

8 months ago·London, United Kingdom

Read Full Article

Reuters

Explainer: How will the Supreme Court reshape US opioid epidemic relief?

The U.S. Supreme Court is set on Monday to hear arguments over the legality of a roughly $6 billion bankruptcy settlement involving Purdue Pharma, maker of the powerful and highly addictive pain medication OxyContin that played a key role in the country's opioid epidemic.

8 months ago·United Kingdom

Read Full Article

Associated Press News

The Supreme Court wrestles with OxyContin maker's bankruptcy deal, with billions of dollars at stake

The Supreme Court is wrestling with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over

8 months ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year